<DOC>
	<DOCNO>NCT01555346</DOCNO>
	<brief_summary>Whole blood sample collect high-risk pregnant woman validate clinical performance SEQureDx Trisomy 21 Test .</brief_summary>
	<brief_title>Clinical Evaluation SEQureDx T21 Test In High Risk Pregnancies</brief_title>
	<detailed_description />
	<mesh_term>Down Syndrome</mesh_term>
	<mesh_term>Aneuploidy</mesh_term>
	<criteria>Pregnant woman 18 year age old 10 22 week gestation inclusive Subject one high risk indicator fetal chromosome 21 aneuploidy Subject provide sign date informed consent Subject agree provide whole blood sample Fetal demise time blood draw Previous specimen donation protocol</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Down syndrome</keyword>
	<keyword>fetal aneuploidy</keyword>
	<keyword>trisomy</keyword>
	<keyword>noninvasive prenatal test</keyword>
</DOC>